CN103865069B - There is active target star polymer carrier of physiological environment response function and preparation method thereof - Google Patents
There is active target star polymer carrier of physiological environment response function and preparation method thereof Download PDFInfo
- Publication number
- CN103865069B CN103865069B CN201410062358.7A CN201410062358A CN103865069B CN 103865069 B CN103865069 B CN 103865069B CN 201410062358 A CN201410062358 A CN 201410062358A CN 103865069 B CN103865069 B CN 103865069B
- Authority
- CN
- China
- Prior art keywords
- star
- shaped
- polycaprolactone
- carrier
- physiological environment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 238000005316 response function Methods 0.000 title claims abstract description 15
- 230000008685 targeting Effects 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229920001610 polycaprolactone Polymers 0.000 claims abstract description 24
- 239000004632 polycaprolactone Substances 0.000 claims abstract description 24
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 13
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 11
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 10
- 229920001400 block copolymer Polymers 0.000 claims abstract description 10
- 239000003937 drug carrier Substances 0.000 claims abstract description 6
- 239000003446 ligand Substances 0.000 claims abstract description 5
- 239000002105 nanoparticle Substances 0.000 claims abstract description 4
- 239000012876 carrier material Substances 0.000 claims abstract description 3
- 238000002626 targeted therapy Methods 0.000 claims abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 36
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 17
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 16
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 229920000469 amphiphilic block copolymer Polymers 0.000 claims description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
- 235000019152 folic acid Nutrition 0.000 claims description 8
- 239000011724 folic acid Substances 0.000 claims description 8
- 229960000304 folic acid Drugs 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 7
- 238000000502 dialysis Methods 0.000 claims description 7
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 7
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 7
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 5
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 5
- 150000008064 anhydrides Chemical class 0.000 claims description 5
- 235000011150 stannous chloride Nutrition 0.000 claims description 5
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 229930182830 galactose Natural products 0.000 claims description 4
- 229920005862 polyol Polymers 0.000 claims description 4
- 150000003077 polyols Chemical class 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims description 4
- 238000002390 rotary evaporation Methods 0.000 claims description 4
- 239000001119 stannous chloride Substances 0.000 claims description 4
- 238000000967 suction filtration Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 238000006555 catalytic reaction Methods 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 claims description 2
- 238000012869 ethanol precipitation Methods 0.000 claims description 2
- 150000005846 sugar alcohols Polymers 0.000 claims description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 abstract description 15
- 210000004027 cell Anatomy 0.000 abstract description 8
- YCLSOMLVSHPPFV-UHFFFAOYSA-N disulfide of beta-mercaptopropionic acid Natural products OC(=O)CCSSCCC(O)=O YCLSOMLVSHPPFV-UHFFFAOYSA-N 0.000 description 7
- 239000000693 micelle Substances 0.000 description 6
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 229940041181 antineoplastic drug Drugs 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229940099563 lactobionic acid Drugs 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 150000002224 folic acids Chemical class 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- -1 dithiodipropionic acid cyclic anhydride Chemical class 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 102000006815 folate receptor Human genes 0.000 description 1
- 108020005243 folate receptor Proteins 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 108010072642 galactosyl receptor Proteins 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Abstract
本发明涉及一种具有生理环境响应功能的主动靶向星形聚合物载体及其制备方法,该载体具有对肿瘤细胞有特异靶向功能,并且可响应细胞内的还原环境而快速降解。该载体材料是双亲性星形聚合物,亲水链段材料为末端接有主动靶向配体的聚乙二醇;疏水链段为可降解吸收的星形聚己内酯;亲水和疏水链段之间通过具有生理环境响应功能的二硫键化学连接,形成功能化的星形嵌段共聚物。本发明聚合物可以作为药物载体,在水中通过自组装形成装载药物的纳米颗粒,可用于肿瘤的靶向治疗。
The invention relates to an active targeting star-shaped polymer carrier with a physiological environment response function and a preparation method thereof. The carrier has a specific targeting function for tumor cells and can rapidly degrade in response to a reducing environment in the cell. The carrier material is an amphiphilic star-shaped polymer, and the hydrophilic segment material is polyethylene glycol with an active targeting ligand at the end; the hydrophobic segment is degradable and absorbable star-shaped polycaprolactone; hydrophilic and hydrophobic The segments are chemically connected by disulfide bonds with physiological environment response functions to form functionalized star-shaped block copolymers. The polymer of the present invention can be used as a drug carrier, self-assembled in water to form drug-loaded nanoparticles, and can be used for targeted therapy of tumors.
Description
技术领域technical field
本发明涉及一种具有生理环境响应功能的主动靶向星形聚合物载体的制备方法,属于药物控释技术领域。The invention relates to a preparation method of an active targeting star-shaped polymer carrier with a physiological environment response function, and belongs to the technical field of drug controlled release.
背景技术Background technique
抗癌药物的副作用严重阻碍了其临床应用。为了解决这个问题,目前研究者们多采用纳米颗粒作为药物载体,比如用纳米胶束包载药物,这一应用的主要根据是,聚合物胶束是通过细胞的内吞作用携载抗癌药物进入细胞,绕开了P-糖蛋白,避免药物经胞外分泌外流,从而使药物可以被具有多要耐药性的肿瘤细胞大量吸收,提高了治疗作用并且大大减小了毒副作用。The side effects of anticancer drugs seriously hinder their clinical application. In order to solve this problem, researchers currently use nanoparticles as drug carriers, such as nanomicelles to carry drugs. The main basis for this application is that polymer micelles carry anticancer drugs through endocytosis of cells. Entering cells, bypassing P-glycoprotein, avoiding the outflow of drugs through extracellular secretion, so that drugs can be absorbed in large quantities by tumor cells with multi-drug resistance, improving the therapeutic effect and greatly reducing toxic and side effects.
然而,聚合物胶束在抗癌药物的应用方面还面临着很多挑战,期望是使载药胶束在到达肿瘤细胞之前的血液循环中稳定性良好,又要能选择性地富集在肿瘤部位,并且在肿瘤细胞内部可以快速释放出药物。通过细胞靶向和细胞质内可控释放抗癌药物,是降低肿瘤治疗对正常细胞伤害和克服耐药性问题的关键。因此,制备出结构稳定、具有靶向性和能响应肿瘤细胞内环境而快速释放药物的聚合物载体,是目前肿瘤治疗研究和技术开发的热点。However, polymer micelles still face many challenges in the application of anticancer drugs. It is expected that the drug-loaded micelles will have good stability in the blood circulation before reaching tumor cells, and they must also be selectively enriched in tumor sites. , and the drug can be rapidly released inside the tumor cells. Controlled release of anticancer drugs through cell targeting and cytoplasm is the key to reducing the damage of tumor therapy to normal cells and overcoming the problem of drug resistance. Therefore, the preparation of polymer carriers with stable structure, targeting and rapid release of drugs in response to the environment of tumor cells is a hot spot in the research and technology development of tumor therapy.
在形成胶束的嵌段共聚物结构设计上,两亲性星形聚合物除具备一般两亲性线性嵌段共聚物的性质外,由于多个链段通过共价键连接于一个多官能团核上,还有其特殊的性质。星形聚合物是由至少三个线性高分子链通过化学键连接到同一中心核上所形成的多臂支化聚合物,与线性聚合物相比,具备的独特性质包括:分子表面官能度高,分子链末端带有大量的可供进一步改性的官能团;分子链不易缠结、溶液和本体的粘度明显低于相同分子量的线性聚合物、结晶度较低;分子更易发生微相分离等。综合这些特点,与线性两亲嵌段共聚物相比,星型共聚物在水中更易于形成胶束,同时也具备更好的稳定性。In the structural design of block copolymers forming micelles, amphiphilic star polymers not only have the properties of general amphiphilic linear block copolymers, but also have multiple chain segments connected to a multifunctional core by covalent bonds. In addition, it also has its special properties. Star polymers are multi-arm branched polymers formed by at least three linear polymer chains connected to the same central core through chemical bonds. Compared with linear polymers, they have unique properties including: high molecular surface functionality, The end of the molecular chain has a large number of functional groups that can be further modified; the molecular chain is not easy to entangle, the viscosity of the solution and the bulk is significantly lower than that of the linear polymer of the same molecular weight, and the degree of crystallinity is lower; the molecule is more prone to microphase separation, etc. Based on these characteristics, compared with linear amphiphilic block copolymers, star copolymers are more likely to form micelles in water, and also have better stability.
与人体正常细胞相比,多数肿瘤细胞表面呈现出一些特定受体的高表达,比如叶酸受体、半乳糖基受体等。因此,针对肿瘤细胞表面的特殊受体,在药物载体材料上通过化学键连接一些相应的配体,通过这种受体-配体的特异结合,就可实现药物载体的主动靶向功能。另外,在肿瘤细胞内部,谷胱甘肽含量远高于细胞外的血液中的含量,也大于正常细胞内的浓度。根据这个生理环境特征,我们可以在聚合物的亲水和疏水链段之间连接具有生理环境响应功能的二硫键,就可以实现载体在肿瘤细胞内还原条件下快速裂解断裂,释放药物导致肿瘤细胞快速凋亡。Compared with normal human cells, the surface of most tumor cells exhibits high expression of some specific receptors, such as folate receptors and galactosyl receptors. Therefore, for the special receptors on the surface of tumor cells, some corresponding ligands are connected to the drug carrier material through chemical bonds. Through the specific binding of this receptor-ligand, the active targeting function of the drug carrier can be realized. In addition, inside the tumor cells, the content of glutathione is much higher than that in the blood outside the cells, and also higher than that in normal cells. According to the characteristics of this physiological environment, we can link disulfide bonds with physiological environment response functions between the hydrophilic and hydrophobic segments of the polymer, so that the carrier can be rapidly cleaved and broken under reducing conditions in tumor cells, releasing drugs to cause tumors Cells undergo rapid apoptosis.
目前,中国专利申请200910273157.0和201110004873.6公布了含有二硫键的共聚物的制备方法,但是未涉及载体的靶向,以及载体聚合物不是星形聚合物。根据前面的分析,这些聚合物材料不能实现载体在血液循环中的稳定性,也不能实现对肿瘤治疗的靶向治疗性。但是,在我们涉及的这个体系中,我们根据肿瘤的生理环境特征,设计了一种既能在血液循环中保持稳定,又能对肿瘤细胞靶向和能响应细胞内还原条件而快速裂解断高分子链,快速释放出抗肿瘤药物的星形聚合物载体。该载体在体内还能完全生物降解。Currently, Chinese patent applications 200910273157.0 and 201110004873.6 disclose preparation methods of copolymers containing disulfide bonds, but do not involve the targeting of the carrier, and the carrier polymer is not a star polymer. According to the previous analysis, these polymer materials cannot achieve the stability of the carrier in the blood circulation, nor can it achieve the targeted therapeutic properties for tumor treatment. However, in our system, according to the characteristics of the tumor's physiological environment, we designed a high-efficiency protein that can not only maintain stability in blood circulation, but also target tumor cells and rapidly lyse in response to intracellular reducing conditions. Molecular chains, star-shaped polymer carriers for rapid release of antitumor drugs. The carrier is also completely biodegradable in vivo.
发明内容Contents of the invention
本发明目的是提供一种具有生理环境响应功能的主动靶向星形聚合物载体的制备方法。使其获得的星形聚合物保证载体在血液循环中保持稳定性。The purpose of the present invention is to provide a preparation method of an active targeting star-shaped polymer carrier with physiological environment response function. The resulting star polymer ensures the stability of the carrier in the blood circulation.
一种具有生理环境响应功能的主动靶向星形聚合物载体的制备方法,包含如下的步骤:A method for preparing an active targeting star-shaped polymer carrier with a physiological environment response function, comprising the following steps:
(1)星形聚己内酯的制备:以氯化亚锡为催化剂,加入多元醇和己内酯,在抽真空3小时后,于温度150度开环聚合,反应6小时合成理论分子量8000的星形聚己内酯,产物冷却后,以二氯甲烷溶解,在大量冰乙醇中沉析,抽滤,产物真空干燥,即得星形聚己内酯的制备;(1) Preparation of star-shaped polycaprolactone: take stannous chloride as a catalyst, add polyol and caprolactone, and after vacuuming for 3 hours, ring-opening polymerization at a temperature of 150 degrees, react for 6 hours to synthesize polycaprolactone with a theoretical molecular weight of 8000 Star-shaped polycaprolactone, the product is cooled, dissolved in dichloromethane, precipitated in a large amount of ice ethanol, filtered with suction, and the product is vacuum-dried to obtain the preparation of star-shaped polycaprolactone;
(2)、星形聚己内酯末端引入二硫键:环状二硫代二丙酸酐与(1)所得星形聚己内酯末端羟基反应,以二甲基甲酰胺DMF做溶剂,加入4-二甲氨基吡啶DMAP和三乙胺催化反应进行,在35度水浴条件下,搅拌反应24h;反应结束后,用0.1M稀盐酸来酸化反应液,将反应液倒入六倍体积的蒸馏水中,用二倍体积的二氯甲烷萃取三次,收集二氯甲烷层,加入无水硫酸钠除水,过滤后将澄清滤液旋蒸、冰乙醚沉析、抽滤,得以分子式PER-(PCL-SS-COOH)4为主体的两亲嵌段共聚物;(2) Disulfide bonds are introduced at the end of star-shaped polycaprolactone: cyclic dithiodipropionic anhydride reacts with terminal hydroxyl groups of star-shaped polycaprolactone obtained in (1), using dimethylformamide DMF as solvent, adding The catalyzed reaction of 4-dimethylaminopyridine DMAP and triethylamine is carried out, and the reaction is stirred for 24 hours under the condition of a 35-degree water bath; after the reaction, the reaction solution is acidified with 0.1M dilute hydrochloric acid, and the reaction solution is poured into six times the volume of distilled water , extracted three times with double the volume of dichloromethane, collected the dichloromethane layer, added anhydrous sodium sulfate to remove water, and filtered the clarified filtrate by rotary evaporation, precipitation with ice ether, and suction filtration to obtain the molecular formula PER-(PCL- SS-COOH)4 is the amphiphilic block copolymer of the main body;
(3)、两亲性星形嵌段共聚物的形成:称取1当量的疏水链段产物(PER-(PCL-SS-COOH)4)溶于一定量DMF中,将此溶液用恒压滴液漏斗慢慢滴入到8~10当量氨基化PEG的DMF溶液中,在催化剂NHS和DCC存在下,通过酰胺键连接成两亲性的嵌段共聚物,反应液过滤、旋转蒸发、冰乙醇沉析,得两亲性星形嵌段共聚物;(3) Formation of amphiphilic star-shaped block copolymer: Weigh 1 equivalent of the hydrophobic segment product (PER-(PCL-SS-COOH)4) and dissolve it in a certain amount of DMF. The dropping funnel was slowly dropped into the DMF solution of 8-10 equivalents of aminated PEG. In the presence of catalysts NHS and DCC, amphiphilic block copolymers were formed through amide bonds. The reaction liquid was filtered, rotated and evaporated on ice. Ethanol precipitation to obtain amphiphilic star-shaped block copolymer;
(4)、具有生理环境响应功能的主动靶向星形聚合物载体的制备:活化后的靶向材料与上一步制备的两亲嵌段共聚物以当量比4:1反应,室温搅拌24h,溶剂为二甲亚砜DMSO;反应结束后,用截留分子量1000克/摩尔的透析袋透析3天,透析结束后,冷冻干燥得最终目标产物。(4) Preparation of active targeting star-shaped polymer carrier with physiological environment response function: the activated targeting material reacts with the amphiphilic block copolymer prepared in the previous step at an equivalent ratio of 4:1, and stirs at room temperature for 24 hours. The solvent is dimethyl sulfoxide DMSO; after the reaction, dialyze with a dialysis bag with a molecular weight cut-off of 1000 g/mole for 3 days, and after the dialysis, freeze-dry to obtain the final target product.
本发明方法的原料低廉易得,方法成熟简单,应用前景广。涉及的各个步骤与方法,本领域的技术人员均能实现。The raw materials of the method of the invention are cheap and easy to obtain, the method is mature and simple, and the application prospect is wide. All involved steps and methods can be realized by those skilled in the art.
本发明的目的还在于,以上述手段获得的目标物。The object of the present invention is also the object obtained by the above means.
一种具有生理环境响应功能的主动靶向星形聚合物载体,该载体材料是具有四臂或六臂星形结构的双亲性星形聚合物,亲水链段材料为末端接有主动靶向配体的聚乙二醇;疏水链段为可降解吸收的星形聚己内酯;亲水和疏水链段之间通过具有生理环境响应功能的二硫键连接,形成功能化的星形嵌段共聚物,这种聚合物可以作为药物载体,在水中通过自组装形成装载药物的纳米颗粒,用于肿瘤的靶向治疗。An active targeting star polymer carrier with physiological environment response function, the carrier material is an amphiphilic star polymer with a four-arm or six-arm star structure, and the hydrophilic segment material is terminated with an active targeting The polyethylene glycol of the ligand; the hydrophobic segment is a degradable and absorbable star-shaped polycaprolactone; the hydrophilic and hydrophobic segments are connected by a disulfide bond with a physiological environment response function to form a functional star-shaped insert Segment copolymers, this polymer can be used as a drug carrier, and self-assemble in water to form drug-loaded nanoparticles for targeted therapy of tumors.
这样,靶向分子的引入使载药胶束有选择性地富集在肿瘤细胞周围,并通过受体介导的内吞作用进入肿瘤细胞;在的聚合物亲水和疏水链段之间连接的具有生理环境响应功能的二硫键,可以使载体在肿瘤细胞内还原条件下快速裂解断裂,释放药物导致肿瘤细胞快速凋亡。疏水链段主要组分为聚己内酯成分,可以在体内完全生物降解。因此,该载体可以提高肿瘤的治疗效果,同时可以减小药物的毒副作用。In this way, the introduction of targeting molecules makes the drug-loaded micelles selectively enrich around the tumor cells and enter into the tumor cells through receptor-mediated endocytosis; linking between the hydrophilic and hydrophobic segments of the polymer The disulfide bond with the function of responding to the physiological environment can make the carrier rapidly cleaved and broken under reducing conditions in the tumor cells, releasing the drug and causing the rapid apoptosis of the tumor cells. The main component of the hydrophobic segment is polycaprolactone, which can be completely biodegraded in vivo. Therefore, the carrier can improve the therapeutic effect of tumors and reduce the toxic and side effects of drugs.
附图说明Description of drawings
图1星形聚己内酯的合成路线。The synthetic route of Fig. 1 star polycaprolactone.
图2两亲性星形嵌段共聚物的合成路线。Fig. 2 Synthetic route of amphiphilic star block copolymer.
图3靶向材料的合成路线。Figure 3 The synthetic route of targeting materials.
具体实施方式detailed description
(1)星形聚己内酯的制备(合成路线如图1所示):以氯化亚锡为催化剂,多元醇为星形结构的核。通常,对于1当量的季戊四醇,投入70当量的己内酯,总质量1%的氯化亚锡,使合成理论分子量8000的星形聚己内酯。在抽真空3小时后,于温度150度开环聚合,反应6小时。产物冷却后,以二氯甲烷溶解,在大量冰乙醇中沉析,抽滤,产物真空干燥,即得四臂聚己内酯。(1) Preparation of star-shaped polycaprolactone (the synthetic route is shown in Figure 1): stannous chloride is used as the catalyst, and polyol is the core of the star-shaped structure. Usually, for 1 equivalent of pentaerythritol, put 70 equivalents of caprolactone and 1% of the total mass of stannous chloride to synthesize star-shaped polycaprolactone with a theoretical molecular weight of 8000. After evacuating for 3 hours, ring-opening polymerization was carried out at a temperature of 150 degrees, and the reaction was carried out for 6 hours. After the product is cooled, it is dissolved in dichloromethane, precipitated in a large amount of ice ethanol, filtered with suction, and the product is vacuum-dried to obtain four-arm polycaprolactone.
以上制备过程中,所使用的作为星型结构的核的分子,可以是丙三醇、季戊四醇和双季戊四醇这类多元醇的一种,分别形成的是三臂、四臂和六臂的星形结构。所设计的这段星形聚合物理论分子量可以是500到10000。In the above preparation process, the molecule used as the core of the star structure can be a kind of polyhydric alcohol such as glycerol, pentaerythritol and dipentaerythritol, which respectively form three-arm, four-arm and six-arm star structure. The theoretical molecular weight of the designed star-shaped polymer can be 500 to 10,000.
(2)二硫代二丙酸环状酸酐的制备:一定量二硫代二丙酸在乙酰氯中温度65度回流反应,可得二硫代二丙酸的环状内酸酐。(2) Preparation of dithiodipropionic acid cyclic anhydride: A certain amount of dithiodipropionic acid is refluxed in acetyl chloride at a temperature of 65 degrees to obtain the cyclic internal anhydride of dithiodipropionic acid.
(3)星形聚己内酯末端引入二硫键:上述合成的环状二硫代二丙酸酐与星形聚己内酯末端羟基可反应,以二甲基甲酰胺(DMF)做溶剂,加入4-二甲氨基吡啶(DMAP)和三乙胺催化反应进行,在35度水浴条件下,搅拌反应24h。反应结束后,用0.1M稀盐酸来酸化反应液。将反应液倒入六倍体积的蒸馏水中,用二倍体积的二氯甲烷萃取三次。收集二氯甲烷层,加入无水硫酸钠除水。过滤,将澄清滤液旋蒸、冰乙醚沉析、抽滤,得产物。产物分子式PER-(PCL-SS-COOH)4。(3) Disulfide bonds are introduced at the end of the star-shaped polycaprolactone: the cyclic dithiodipropionic anhydride synthesized above can react with the terminal hydroxyl group of the star-shaped polycaprolactone, and dimethylformamide (DMF) is used as the solvent. Add 4-dimethylaminopyridine (DMAP) and triethylamine to catalyze the reaction, and stir the reaction for 24 hours under the condition of 35 degree water bath. After the reaction, the reaction solution was acidified with 0.1M dilute hydrochloric acid. The reaction solution was poured into six volumes of distilled water, and extracted three times with two volumes of dichloromethane. The dichloromethane layer was collected, and anhydrous sodium sulfate was added to remove water. After filtration, the clarified filtrate was rotary evaporated, precipitated with glacial ether, and suction filtered to obtain the product. The molecular formula of the product is PER-(PCL-SS-COOH)4.
(4)双氨基化聚乙二醇的制备:采用Gabriel法进行聚乙二醇的氨基化。对于PEG双端氨基化的方法,也可以使用其他成熟的氨基化方法,例如,用PEG合成磺酰化的PEG后,高温高压釜中与氨水反应。(4) Preparation of bis-aminated polyethylene glycol: Gabriel method was used to aminate polyethylene glycol. For the method of amination of both ends of PEG, other mature amination methods can also be used, for example, after PEG is used to synthesize sulfonylated PEG, it is reacted with ammonia water in a high temperature and autoclave.
(5)两亲性星形嵌段共聚物的形成(如合成路线图2所示):根据上述方案,称取1当量的疏水链段产物(PER-(PCL-SS-COOH)4)溶于一定量DMF中,将此溶液用恒压滴液漏斗慢慢滴入到8~10当量氨基化PEG的DMF溶液中,在催化剂NHS和DCC存在下,通过酰胺键连接成两亲性的嵌段共聚物。反应液过滤、旋转蒸发、冰乙醇沉析,得产物。(5) Formation of amphiphilic star-shaped block copolymer (as shown in the synthetic route diagram 2): according to the above scheme, weigh 1 equivalent of the hydrophobic segment product (PER-(PCL-SS-COOH)4) In a certain amount of DMF, the solution is slowly dropped into the DMF solution of 8-10 equivalents of aminated PEG with a constant pressure dropping funnel, and in the presence of catalysts NHS and DCC, the amphiphilic intercalation is formed by amide bonds. segment copolymers. The reaction solution was filtered, rotary evaporated, and precipitated with ice ethanol to obtain the product.
(6)靶向材料的制备:靶向分子的来源可以是叶酸和半乳糖分子中的一种,其受体均有在人体肿瘤细胞表面过量表达的情况。(6) Preparation of targeting materials: The source of targeting molecules can be one of folic acid and galactose molecules, and their receptors are overexpressed on the surface of human tumor cells.
(a)叶酸靶向材料的制备(如合成路线图3所示):叶酸经等当量的NHS和DCC在冰水浴条件下活化。活化后的叶酸与上一步制备的两亲嵌段共聚物以当量比4:1反应,室温搅拌24h,溶剂为二甲亚砜(DMSO)。反应结束后,用截留分子量1000克/摩尔的透析袋透析3天。透析结束后,冷冻干燥得最终产物,具有叶酸靶向基团并且有二硫键的星形聚合物。(a) Preparation of folic acid-targeting materials (as shown in the synthetic route diagram 3): folic acid was activated by equivalent amounts of NHS and DCC under ice-water bath conditions. The activated folic acid was reacted with the amphiphilic block copolymer prepared in the previous step at an equivalent ratio of 4:1, stirred at room temperature for 24 h, and the solvent was dimethyl sulfoxide (DMSO). After the reaction was finished, dialyze for 3 days with a dialysis bag with a molecular weight cut-off of 1000 g/mol. After dialysis, freeze-dry to obtain the final product, a star polymer with folic acid targeting groups and disulfide bonds.
(b)半乳糖靶向材料的制备:制备方法与上同,将叶酸换成乳糖酸,就可得到有半乳糖靶向基团并且有二硫键的星形聚合物。(b) Preparation of galactose-targeting material: the preparation method is the same as above, replacing folic acid with lactobionic acid to obtain a star-shaped polymer with galactose-targeting groups and disulfide bonds.
实施例1Example 1
称取0.17克季戊四醇,10克己内酯和0.1克氯化亚锡,置于单口瓶中,抽真空3h后,在温度150度条件下开环聚合,6小时后取出,待产物从熔融冷却为固体状态,加入5mL二氯甲烷使溶解,滴入到250mL冰乙醇中沉析,抽滤,真空干燥,即得四臂聚己内酯。Take by weighing 0.17 gram of pentaerythritol, 10 gram of caprolactone and 0.1 gram of tin protochloride, place in a one-necked bottle, after vacuumizing for 3 hours, ring-opening polymerization under the condition of temperature 150 degrees, take out after 6 hours, treat that the product cools from melting to In solid state, add 5 mL of dichloromethane to dissolve, drop into 250 mL of ice ethanol for precipitation, filter with suction, and dry in vacuum to obtain four-arm polycaprolactone.
称取2克二硫代二丙酸,加入20克乙酰氯,在温度65度回流反应,磁力搅拌4h后,旋转蒸发除去大部分有机溶剂,用冰乙醚沉析,抽滤,真空干燥,即得。Weigh 2 grams of dithiodipropionic acid, add 20 grams of acetyl chloride, reflux reaction at a temperature of 65 degrees, stir magnetically for 4 hours, remove most of the organic solvent by rotary evaporation, precipitate with glacial ether, filter with suction, and dry in vacuum, namely have to.
称取1份二硫代二丙酸酐与5.2克上述的星形聚己内酯,加入到70mLDMF中,催化剂DMAP0.3176克,三乙胺0.4mL,在温度35度水浴条件下,搅拌反应24h。反应结束后,用配置好的0.1M盐酸调节pH值为5,然后将该反应液倒入六倍体积的蒸馏水中,用二倍体积的二氯甲烷萃取,共萃取三次。收集下部二氯甲烷层,加入无水硫酸钠除水。待液体层澄清,过滤掉硫酸钠,将滤液旋蒸,大量冰乙醚沉析、抽滤,得产物。产物分子式PER-(PCL-SS-COOH)4。Weigh 1 part of dithiodipropionic anhydride and 5.2 grams of the above-mentioned star-shaped polycaprolactone, add them to 70 mL of DMF, catalyst DMAP 0.3176 grams, triethylamine 0.4 mL, and stir for 24 hours under the condition of a water bath at a temperature of 35 degrees . After the reaction, adjust the pH value to 5 with the prepared 0.1M hydrochloric acid, then pour the reaction solution into six times the volume of distilled water, and extract with two times the volume of dichloromethane for a total of three extractions. The lower dichloromethane layer was collected, and anhydrous sodium sulfate was added to remove water. After the liquid layer was clarified, sodium sulfate was filtered off, the filtrate was rotary evaporated, a large amount of glacial ether was precipitated, and the product was obtained by suction filtration. The molecular formula of the product is PER-(PCL-SS-COOH)4.
称3克双氨基化的聚乙二醇(PEG)溶于50mLDMF中,置于三口烧瓶中,另外称1.2克疏水链段产物PER-(PCL-SS-COOH)4溶于30mLDMF中,将此溶液慢慢滴入到氨基化聚乙二醇的DMF溶液中,加入催化量的NHS和DCC,室温反应24h。反应液过滤、旋蒸、大量冰乙醇沉析、抽滤,重复三次,真空干燥得到星形两亲性嵌段共聚物产物。Dissolve 3 grams of diaminated polyethylene glycol (PEG) in 50 mL of DMF and place it in a three-necked flask. In addition, weigh 1.2 grams of the hydrophobic segment product PER-(PCL-SS-COOH)4 and dissolve it in 30 mL of DMF. The solution was slowly dropped into the DMF solution of aminated polyethylene glycol, and a catalytic amount of NHS and DCC was added, and the reaction was carried out at room temperature for 24 hours. Filtration of the reaction solution, rotary evaporation, precipitation with a large amount of ice ethanol, and suction filtration were repeated three times, followed by vacuum drying to obtain a star-shaped amphiphilic block copolymer product.
称0.022克叶酸,0.0103克DCC,0.0058克NHS,加入20mL二甲亚砜(DMSO)中磁力搅拌12h,前2h在冰水浴条件下进行。称上步已经合成的星形两亲性嵌段共聚物产物3克,溶于50mLDMSO中,活化好的叶酸溶液滴入该聚合物溶液中,反应24h。反应结束后,用截留分子量1000克/摩尔的透析袋透析3天,冷冻干燥得最终产物:具有生理环境响应功能的主动靶向四臂星形聚合物载体。Weigh 0.022 g of folic acid, 0.0103 g of DCC, and 0.0058 g of NHS, add them into 20 mL of dimethyl sulfoxide (DMSO) and stir magnetically for 12 h, and carry out the first 2 h in an ice-water bath. Weigh 3 grams of the star-shaped amphiphilic block copolymer product synthesized in the previous step, dissolve it in 50 mL of DMSO, and drop the activated folic acid solution into the polymer solution, and react for 24 hours. After the reaction, it was dialyzed for 3 days with a dialysis bag with a molecular weight cut-off of 1000 g/mole, and then freeze-dried to obtain the final product: an active targeting four-armed star-shaped polymer carrier with a physiological environment response function.
实施例2Example 2
本例是将实施例1中的季戊四醇换做双季戊四醇,投入的双季戊四醇与己内酯的比例为1:105,其他实施方法实施例1,以此得到六臂的星形共聚物。In this example, the pentaerythritol in Example 1 was replaced with dipentaerythritol, and the ratio of dipentaerythritol to caprolactone was 1:105. Other implementation methods in Example 1 were used to obtain a six-armed star-shaped copolymer.
实施例3Example 3
本例是将实施例1中的叶酸分子换做乳糖酸其他方法同实施例1,可以合成得到有半乳糖靶向基团并且有二硫键的星形四臂聚合物。In this example, the folic acid molecule in Example 1 is replaced with lactobionic acid. Other methods are the same as in Example 1, and a star-shaped four-armed polymer with galactose targeting groups and disulfide bonds can be synthesized.
实施例4Example 4
本例是将实施例1中的叶酸分子换做乳糖酸,季戊四醇换做双季戊四醇,其他方法同实施例1,可以合成得到有半乳糖靶向基团并且有二硫键的星形六臂聚合物。In this example, the folic acid molecule in Example 1 is replaced by lactobionic acid, and the pentaerythritol is replaced by dipentaerythritol. The other methods are the same as in Example 1, and a star-shaped six-armed polymer with a galactose targeting group and a disulfide bond can be synthesized. things.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410062358.7A CN103865069B (en) | 2014-02-24 | 2014-02-24 | There is active target star polymer carrier of physiological environment response function and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410062358.7A CN103865069B (en) | 2014-02-24 | 2014-02-24 | There is active target star polymer carrier of physiological environment response function and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103865069A CN103865069A (en) | 2014-06-18 |
CN103865069B true CN103865069B (en) | 2016-05-18 |
Family
ID=50904116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410062358.7A Expired - Fee Related CN103865069B (en) | 2014-02-24 | 2014-02-24 | There is active target star polymer carrier of physiological environment response function and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103865069B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105968370B (en) * | 2016-06-22 | 2019-05-24 | 国家纳米科学中心 | The polyethylene glycol polycaprolactone triblock polymer and its preparation method and application of triple disulfide bond connections |
CN108299649B (en) * | 2017-01-13 | 2021-06-15 | 上海干云生物科技有限公司 | Multi-arm star-shaped block polymer and preparation method and application thereof |
CN107744503B (en) * | 2017-08-14 | 2020-04-07 | 浙江工业大学 | Preparation method of enzyme-sensitive amphiphilic polyester MePEG-Peptide-PER-CL administration nanoparticle |
CN115191428B (en) * | 2022-07-25 | 2023-08-22 | 西安交通大学 | Amphiphilic star-type polymer-loaded pesticide preparation and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101953804A (en) * | 2010-09-26 | 2011-01-26 | 苏州同科生物材料有限公司 | Shell layer dropping type nanometer medicine carrier preparation based on amphiphilic block copolymer and preparation method thereof |
CN102397236A (en) * | 2010-09-16 | 2012-04-04 | 同济大学 | Method for preparing shell-sheddable polymer micelle drug carrier |
CN102423302A (en) * | 2011-11-21 | 2012-04-25 | 中国药科大学 | Picropodophyllin-loaded nano-micelle preparation and freeze-dried preparation and preparation method thereof |
-
2014
- 2014-02-24 CN CN201410062358.7A patent/CN103865069B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102397236A (en) * | 2010-09-16 | 2012-04-04 | 同济大学 | Method for preparing shell-sheddable polymer micelle drug carrier |
CN101953804A (en) * | 2010-09-26 | 2011-01-26 | 苏州同科生物材料有限公司 | Shell layer dropping type nanometer medicine carrier preparation based on amphiphilic block copolymer and preparation method thereof |
CN102423302A (en) * | 2011-11-21 | 2012-04-25 | 中国药科大学 | Picropodophyllin-loaded nano-micelle preparation and freeze-dried preparation and preparation method thereof |
Non-Patent Citations (4)
Title |
---|
A convenient scheme for synthesizing reduction-sensitive chitosan-based amphiphilic copolymers ofr drug delivery;Cao Moyuan et al.;《Journal of Applied Polymer Science》;20110902;第123卷(第5期);3137-3144 * |
Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy;Huanli Sun et al.;《Expert Opinion on Drug Delivery》;20130322;第10卷(第8期);1109-1122 * |
Shell-sheddable micelles based on star-shaped poly(E-caprolactone)-SS-poly(ethyl glycol)copolymer for intracellular drug release;Tian-Bin Ren et al.;《Soft matter》;20110215;2329-2331 * |
以聚己内酯为疏水性嵌段的两亲性星形聚合物的合成、表征和性能研究;周建华;《中国博士学位论文全文数据库(电子期刊)》;20120315;B014-6 * |
Also Published As
Publication number | Publication date |
---|---|
CN103865069A (en) | 2014-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104056275B (en) | Synthesis of multifunctional active targeting hyaluronic acid-polylactic acid carrier and preparation method of anti-tumor drug micelles | |
CN102276813B (en) | Targeting polymer drug carrier containing folic acid and preparation method thereof | |
CN105251013B (en) | One kind having degradable water-soluble antitumor polymeric prodrugs of redox response and preparation method thereof | |
Ha et al. | Self-aggregates of cholesterol-modified carboxymethyl konjac glucomannan conjugate: Preparation, characterization, and preliminary assessment as a carrier of etoposide | |
CN108926531B (en) | A kind of reduction and pH dual responsive nanomicelle and its preparation method and application | |
CN103865069B (en) | There is active target star polymer carrier of physiological environment response function and preparation method thereof | |
CN107952079B (en) | Combined administration thermal gel sustained-release injection and preparation method thereof | |
CN107669626B (en) | Preparation method and application of a reduction-sensitive drug delivery system with high drug loading | |
CN105384920B (en) | Polymer and the preparation method and application thereof of the one kind containing selenium or tellurium | |
CN103242519B (en) | Amphiphilic polymer as well as preparation method and application thereof | |
CN106317416A (en) | Double-pH-response amphiphilic copolymer and preparation method and application thereof | |
CN106589271A (en) | Degradable reversible crosslinking polymer based on dynamic chemical bond and micelle thereof, preparation method and application | |
CN107137716A (en) | A kind of polyethylene glycol conjugation circular polypeptides iRGD and diosgenin medicine-carried nano particles preparation | |
CN107141323A (en) | Reduction/pH dual responsiveness adriamycin prodrugs and preparation method and application | |
CN104162166B (en) | pH sensitive polysaccharide nano drug-loaded micelles and preparation method thereof | |
CN102406946A (en) | High molecular adriamycin bonded medicament and preparation method thereof | |
CN104622813B (en) | A kind of nanoparticle formed based on host-guest interaction and its preparation method and purposes | |
CN103083682B (en) | Folic acid modified chitosan quaternary ammonium salt-taxol polymer medicine, as well as preparation method and application thereof | |
CN104523598B (en) | Glucan/adriamycin bonding medicine nano grain and preparation method thereof | |
CN101234205A (en) | Polymer doxorubicin-bonded drug nanocapsule with targeting function and preparation method thereof | |
CN104045837B (en) | A kind of three-arm star-shaped hydrophilic copolymers and synthetic method thereof and application | |
CN105968370A (en) | Triple disulfide-bond linked polyethylene glycol-polycaprolactone triblock copolymer as well as preparation method and application thereof | |
CN106008964B (en) | A kind of water-soluble amino acid block copolymer and its preparation method and application | |
CN105796529B (en) | A kind of preparation method and applications of gambogicacid self-assembling polymers nanoparticle | |
CN104892807B (en) | Surface saccharide-modified polymer micelle, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160518 Termination date: 20190224 |
|
CF01 | Termination of patent right due to non-payment of annual fee |